# A Study of Luffa Operculate Nasal Solution 5mg/mL Compared With Saline (NaCl 09%) for the Relief of Nasal Obstruction

> **NCT01248325** · PHASE3 · UNKNOWN · sponsor: **Zurita Laboratorio Farmaceutico Ltda.** · enrollment: 60 (estimated)

## Conditions studied

- Rhinitis
- Sinusitis

## Interventions

- **DRUG:** Luffa Operculate Nasal Solution 5mg/mL
- **DRUG:** Saline Solution (NaCl 0,9%)

## Key facts

- **NCT ID:** NCT01248325
- **Lead sponsor:** Zurita Laboratorio Farmaceutico Ltda.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2011-01
- **Primary completion:** 2011-07
- **Final completion:** 2011-07
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2010-11-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01248325

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01248325, "A Study of Luffa Operculate Nasal Solution 5mg/mL Compared With Saline (NaCl 09%) for the Relief of Nasal Obstruction". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT01248325. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*